•
•
•
•
| |||||
|
| |||||
|
Advances in Uterine Leiomyoma Research:
2nd NIH International Congress FEBRUARY 24-25, 2005 Natcher Conference Center National Institutes of Health Bethesda, MD 20892 Sponsored by: NATIONAL INSTITUTES OF HEALTH Office of Research on Women’s Health National Institute of Environmental Health Sciences National Institute of Child Health and Human Development National Cancer Institute National Center for Research Resources National Institute of Biomedical Imaging and Bioengineering and AGENCY FOR HEALTHCARE RESEARCH AND QUALITY CENTERS FOR DISEASE CONTROL AND PREVENTION FOOD AND DRUG ADMINISTRATION OFFICE ON WOMEN’S HEALTH, OFFICE OF THE SECRETARY SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION | |||||
|
| |||||
|
Women's Health in Primary Care Journal Summary Article, "Advances in Uterine
Leiomyoma Research" (PDF format) |
|||||
|
2nd NIH International Congress February 24 – 25, 2005 National Institutes of Health Bethesda, MD Uterine leiomyoma (fibroids) are the most common gynecologic neoplasm in women of reproductive age. As the number one cause of hysterectomy, they have a profound negative impact on women’s health. Uterine leiomyoma are hormonally dependent and as such are a potential target for endocrine active compounds in the environment. The goal of this conference is to bring together researchers working in the fields of biomedicine, epidemiology, basic research, therapeutics and translational medicine to foster an exchange of scientific information among members of the uterine leiomyoma research and health care communities. Participants will be drawn from academia, medicine, government, and industry. Topics to be covered include Clinical Experience and Therapeutic Strategies, Epidemiology, Clinical Trials, Pathogenesis of Smooth Muscle Tumors, and Molecular and Genetic Characteristics. | |||||
|
| |||||
|
